Updated: 9/23/2005; 3:30:25 PM.
Personal Injury Lawyers' Radio Weblog
        

Friday, September 23, 2005

Check out the Guidant Recall Lawyer Blogs!!!
3:30:24 PM    comment []

Wednesday, September 21, 2005

FDA Preliminary Public Health Notification*: Guidant VENTAK PRIZM® 2 DR and CONTAK RENEWAL® Implantable Cardioverter Defibrillators

Date: July 14, 2005

This is to provide clinicians with current information and guidance concerning malfunctions occurring with Guidant’s PRIZM® 2 and CONTAK RENEWAL® implantable cardioverter defibrillator (ICD) devices, which were the subjects of a Class I recall announced by FDA on July 1, 2005.

The affected devices are:

The malfunction that is the subject of the recall causes damage to the device’s circuitry, potentially resulting in the inability to deliver the required shock during episodes of arrhythmia. This malfunction could lead to a serious, life-threatening event. Importantly, the device does not give any sign of impending failure, and there is no test that predicts whether any particular device will fail. At this time it is not possible to provide accurate estimates of the failure rate for these devices, but at least two deaths attributable to this failure mode have been reported.

Recommendations:

If this failure mode is demonstrated to have occurred, the device should be replaced. However, the FDA is not making a recommendation on whether patients who have one of these devices should have it replaced under other circumstances. We believe that this decision must be made by the patient in consultation with his or her physician, and should be based on the patient’s condition, medical history, and other pertinent factors.

We recommend that you:

  1. Contact each of your patients affected by the recall, and advise coming in for an evaluation if he or she has not been seen recently. Discuss with the patient the factors that will enter into the decision regarding replacement, including medical history, the risks of replacement, device battery status, and the likelihood that this patient will require the defibrillation or pacing features of the device in the future. You may wish to provide a copy of FDA’s “Advice to Patients with VENTAK PRIZM® 2 DR and CONTAK RENEWAL® Implantable Cardioverter Defibrillators” http://www.fda.gov/cdrh/medicaldevicesafety/atp/071405-guidant.html to your patients.

    If the device is to be left in place, advise patients to:

    • continue with their regularly-scheduled follow-up appointments;

    • contact you as soon as possible if they receive a shock from the device;

    • go immediately to your office or clinic, or to an emergency room, if they hear a “beeping” noise coming from the ICD, because this may mean that the device is damaged.

  2. Verify normal device function at every patient visit, using routine clinical follow-up procedures.

    • If a shock was delivered since the prior follow-up visit, check for out-of-range values in the “Last Delivered Shock” impedance as stored in the device’s memory.

    • Follow the manufacturer’s instructions for evaluating warning screens encountered during interrogation of the patient’s device.

    • Also check for other indicators of device malfunction, including loss of the telemetry, programming, or interrogation functions, loss of tachyarrhthmia detection and therapy, and a decrease in pacing output.

  3. In order to better characterize the failure rate, it is essential that you return all explanted devices to the manufacturer for analysis, regardless of the reason for explant. All returned devices, including those that are still functional at the time of explant, are analyzed by the company to better understand their performance. In the case of patients who die with an implant, we strongly encourage interrogation and, if possible, explantation and return of the ICD.

     

  4. Because there are no signs of impending device failure, and there is no test that predicts whether any particular device will fail, FDA has concluded that there is insufficient evidence at this time to support the value of a commanded shock.

Failure Mode Information

Guidant’s laboratory analysis has determined that a breach in insulation surrounding a high voltage wire within the lead connector block, in conjunction with other circumstances, can allow undesirable shunting of energy to the active titanium case during shock delivery. Diversion of energy away from heart tissue may trigger a programmer screen message upon next interrogation, warning clinicians that full energy was not delivered to the heart during the last shock delivered. If sufficient shock energy is diverted to internal circuitry, it may render the device inoperative, preventing telemetry and delivery of additional shock therapy or bradycardia pacing. Bench testing has shown that the number of shocks delivered does not affect the likelihood of device failure.

In some of the malfunctioning devices investigated by Guidant, a yellow programmer warning screen describing low shock lead impedance or a shorted shocking lead condition was observed upon programmer interrogation post-shock. In each case, clinical evaluation of the lead system did not confirm a lead issue and for this reason each device was explanted and returned to Guidant for analysis. In some of the other cases, the yellow screen did not appear, as circuitry damage prevented programmer telemetry.

In some of the cases, a problem was identified during in-clinic cardioversion for atrial fibrillation. In the remaining cases, patients were away from the clinic, but a warning screen or loss of telemetry was observed when the patient returned to the clinic immediately following shock delivery or for a scheduled office visit.

Reporting Adverse Events to FDA

FDA requires hospitals and other user facilities to report deaths and serious injuries associated with the use of medical devices. If you suspect that a reportable adverse event was related to the use of a Guidant ICD, you should follow the reporting procedure established by your facility. Prompt reporting of adverse events can improve FDA’s understanding of and ability to communicate the risks associated with devices and assist in the identification of potential future problems.


3:22:12 PM    comment []

Thursday, June 09, 2005

Millions 'hit by global warming'. Millions of people in England and Wales are being seriously affected by pollution and global warming, the Environment Agency says. [BBC News | News Front Page | UK Edition]
9:47:55 AM    comment []

Tuesday, June 07, 2005

Social Security Disability Information

Your source for Social Security Disability Benefits information

     All to often, The Social Security Administration (SSA) wrongfully denies Social Security Disability Benefits to truly disabled claimants. Congress has defined "disabled" as:

The inability to engage in any substantial gainful activity by reason of any medically determinable physical or mental impairment which can be expected to result in death or which has lasted or can be expected to last for a continuous period of no less than twelve months.

    For a claimant to be determined "disabled" under disability he or she must have physical or mental impairments to the extent that the severity is to such a great degree that he or she is unable to return to their previous employer due to the fact that they can not perform their pre-injury work place tasks.  Generally, the claimant must also have one of the listed Social Security physical or mental impairments.

     We are The Social Security Law Group and we have designed this web site to offer you useful Social Security resources and assistance in obtaining SSDI benefits.  We are a private law firm (not affiliated with SSA nor any other Federal or State Agency) practicing nationwide exclusively in the area of Social Security Disability Law.  We have dedicated our professional careers to ensuring that eligible disabled claimants who have been wrongfully denied Title II Social Secuirty Disability (SSDI) receive the benefits they rightfully deserve.   If you have questions regarding your claim or potential eligibility, please feel free to contact us using our free case evaluation form. Please remember, we are currently assisting only those claimaints who are eligible for Title II SSDI benefits. 

     Every inquiry we receive is carefully evaluated by one of our experienced SSDI attorneys. We will offer you a free, no obligation evaluation of your Social Security Claim and contact you directly to discuss any additional issues.  You can take advantage of this free service by clicking on the Free Case Evaluation button above. Studies show that a 20-year-old worker has a 3-in-10 chance of becoming disabled before reaching his or her retirement age.

     The Social Security Law Group provides ethical, professional, legal advocacy and has extensive experience in Social Security Disability Law.  We provide quality legal administrative support to claimants who are disabled and are no longer able to work.  We guide and support them with attorney representation in their pursuit of Social Security benefits at all levels of the Social Security Administrative and Judicial process. 

What’s the difference between SSI and SSDI?

     The difference is significant. Below is a brief description of each program and how it works.

SSDI - This is known as Title II (2) Social Security Disability Benefits. This program is for people who have made sufficient FICA (Federal Insurance Contribution Act) contributions in the last 5 years.  We have listed below the minimum amounts of earnings in 2003 to qualify for Title II Disability Benefits.

Year  Amount Per Quarter   Amount Per Year
2003 $890.00   $3,480.00

     For Example: if in 2003, you earned at least $890.00 of gross wages (wages which you or your employer reported and paid FICA taxes), you would have paid for 1 quarter of SSDI coverage. If you earn $3,480.00 in 2003 you are covered for the entire year (4 Quarters). Remember, you need to pay 20 of the last 40 quarters to be eligible for SSDI benefits. Below is the coverage amounts for years 2002 through 1994.

Year Amount Per Quarter Amount Per Year
2002 $870.00 $3,480.00
2001 $830.00 $3,320.00
2000 $780.00 $3,120.00
1999 $740.00 $2,960.00
1998 $700.00 $2,800.00
1997 $670.00 $2,680.00
1996 $640.00 $2,560.00
1995 $630.00 $2,520.00

1994

$620.00 $2,480.00

     If you qualify for SSDI benefits, you must file an application and be deemed medically disabled under SSA’s rules. Once you are approved, you need not worry about other sources of income such as rental income, stocks bonds, etc. Once you start to earn income from “work” or “Substantial Gainful Activity” as SSA deems it,  then these earnings are monitored for purposes of a trial work period. (see this section of our web site for details)

     If you qualify for SSDI benefits, THE SOCIAL SECURITY LAW GROUP® can assist you in your application or appeal. 

SSI—This is known as Title XVI (16) Supplemental Security Income. This program is for people who either:

  • Have not paid enough quarters (earnings) into Social Security for any reason.
    • You must have paid into Social Security through wage and FICA contributions for 20 out of the last 40 quarters.
    • b. If you are unsure, please read the instructions below as to how to confirm if you have paid enough into SSDI.
  • Have limited resources and income

     Although you must be disabled according to SSA’s definition, you must first meet SSA’s strict resource eligibility test prior to your medical condition being considered. If your resources exceed SSA’s limit, you cannot collect SSI irrespective of your medical disability.

     Once you are approved, all your other sources of income will be monitored by SSA to ensure that you continually meet their strict resource requirements. THE SOCIAL SECURITY LAW GROUP® is presently not assisting claimant’s in SSI claims.

 

What if I am not sure if I qualify for SSI or SSDI?

     Some of the people who visit our site and contact us are unsure if they are Title II eligible.  You are encouraged to contact SSA to verify  your eligibility for Title II. To do so, please follow the instructions below:

  • Call the SSA national Toll Free line at 800-772-1213
  • Follow the prompts to speak with a representative
  • Tell the representative you want to file a Disability claim, and you need to know if you are Title 2 or Title 16 eligible. If they tell you that you are Title 2 eligible, please ask them:
  • What is my DATE LAST INSURED?

6:21:54 PM    comment []

Thursday, May 26, 2005

Online Legal Research
Federal Rules of Civil Procedure
Check Standing of Massachusetts Lawyers
Federal Rules of Evidence
State and Federal Laws
Findlaw
Lawyer's Guide to Investigation on the Internet
Court Web Sites
Legal WebLogs

FEDERAL COURTS:
US FEDERAL COURTS
Federal Court Cases

SUPREME COURT:
US Supreme Court Official Site
Supreme Court Decisions
Supreme Court Search

STATE COURTS:
State Court Cases
State Court Directory
The National Center for State Courts

OTHER MASSACHUSETTS LINKS (NON LEGAL)
Massachusetts Deleading Services

MASSACHUSETTS SHOPPING & SERVICES
Boston Video Production
Boston Web Design
Massachusetts Vinyl Siding

Replacement Windows


Asbestos
    
Auto Accidents    
Aviation Accidents    
Birth Injury    
Brain Injury    
Business Litigation    
Cerebral Palsy    
Condominium Law    
Consumer Protection - M.G.L. 93A  
Contract Litigation    
Criminal - Drug Possession    
Defective Drugs    
Dog Bite    
DUI / DWI    
Employment Law    
Estate Planning    
Family Law    
Fraud / Misrepresentation    
Immigration    
Insurance Bad Faith Denial    
Internet Law    
Legal Malpractice    
Medical Malpractice   
Mesothelioma    
Motorcycle Accidents    
Nursing Home Abuse    
Personal Injury    
Purchase & Sale    
Railroad Accident    
Real Estate
    
Sexual Harassment    
ocial Security Disability
  

Spine & Spinal Cord Injury   
Stock & Broker Fraud     Traumatic Brain Injury     Truck Accident     Trusts     Vioxx     Welding Fumes     Workers Compensation     Wrongful Death     Wrongful Discharge     Zicam


4:15:24 PM    comment []

Thursday, May 12, 2005

VIOXX LINKED TO HEART ATTACK AND STROKE

Vioxx, a widely used prescription medicine produced by drug manufacturing giant, Merck & Co., was voluntarily withdrawn on September 30, 2004 due to mounting evidence linking it to increased risk of cardiovascular problems. Following a three-year study involving the drug, researchers concluded that withdrawing Vioxx from the market would be in the best interest of the patients. The drug, a popular pain reliever used worldwide by millions of patients, has also been connected with higher incidences of respiratory and liver and kidney dysfunction.

 

NEWS: 11-10-04 - BEXTRA MORE THAN DOUBLES RISK OF HEART ATTACK - This week, researchers said a preliminary study indicated that Bextra, a painkiller in the same class as Vioxx, more than doubled the risk of heart attack. Bextra has also been linked to strokes, heart disease, Stevens-Johnson syndrome, toxic epidermal necrolysis, exfoliative dermatitis and erythema multiforme. Click Here for more information regarding Bextra.

 

 

 

Vioxx is classified as a COX-2 inhibitor, a type of drug deemed to be safer for the gastrointestinal system than nonsteroidal anti-inflammatory drugs (NSAIDs). Unfortunately, the cardiovascular safety of this drug family has come under enormous scrutiny of late. Studies have shown that individuals taking Vioxx have between a 17 and 24 percent increase in heart attack risk compared to individuals taking comparable pain relief drugs on the market.[1]

 

Vioxx is used extensively for the treatment of many types of pain. While most commonly used to treat arthritis-related pain in its various forms, there are a number of other uses for the drug: 

    • Relief of pain and inflammation of osteoarthritis (arthritis from wear and tear on your bones and your joints)
    • Relief of pain and inflammation of rheumatoid arthritis in adults (arthritis caused by a condition where your immune system attacks your joints)
    • Management of short-term pain
    • Treatment of menstrual pain (pain during women’s monthly periods)
    • Treatment of migraine headache attacks with or without aura.[2]

     Vioxx has been linked to serious cardiovascular events, including heart attacks and strokes.  If you or someone you love has been injured as a result of taking the drug Vioxx, you may be entitled to monetary compensation. For a free review of your claim, please fill our Vioxx Free Consultation form.  Upon submission, your free consultation form will be sent to the sponsored personal injury lawyer for evaluation. That lawyer will personally evaluate your case, and may contact you to further discuss your situation, and/or attempt to refer you to a qualified lawyer who may be able to assist you.  Please be advised that by submitting a free consultation form, you are not entering into an attorney client relationship with the individual firm or lawyer.

 


[1] www.healthfinder.gov/news/newsstory.asp?docID=518497

[2] Patient Information about Vioxx

Bextra Efoliative Dermatitis
Bextra Erythema Multiforme
Bextra Heart Attack
Bextra Heart Disease
Bextra Stroke
Bextra Toxic Epidermal Necrolysis
FDA Vioxx Press Release
FDA: Vioxx Safety
Merck Voluntary Recalls VIOXX
Rofecoxib Recall
Stevens Johnson Syndrome
Vioxx Drug Information
Vioxx has no effect on arteries
Vioxx Q&A
Vioxx Recall News
Bextra Efoliative Dermatitis
Bextra Erythema Multiforme
Bextra Heart Attack
Bextra Heart Disease
Bextra Stroke
Bextra Toxic Epidermal Necrolysis
FDA Vioxx Press Release
FDA: Vioxx Safety
Merck Voluntary Recalls VIOXX
Rofecoxib Recall
Stevens Johnson Syndrome
Vioxx Drug Information
Vioxx has no effect on arteries
Vioxx Q&A
Bextra Efoliative Dermatitis
Bextra Erythema Multiforme
Bextra Heart Attack
Bextra Heart Disease
Bextra Stroke
Bextra Toxic Epidermal Necrolysis
FDA Vioxx Press Release
FDA: Vioxx Safety
Merck Voluntary Recalls VIOXX
Rofecoxib Recall
Stevens Johnson Syndrome
Vioxx Drug Information
Vioxx has no effect on arteries
Vioxx Q&A

8:37:57 PM    comment []

Monday, May 09, 2005

Q.: Where can I find California statutes and laws online?

A.: California Law consists of 29 codes, covering various subject areas, the State Constitution and Statutes. Information presented reflects laws currently in effect. All California Codes have been updated to include the 2003 Statutes.

To display the Table of Contents for a code, click on your area of interest below.

Business and Proffesions Code                    Code Of Civil Procedure

Corporations Code                                       Civil Code                   

Commercial Code                                          Education Code

Elections Code                                              Evidence Code

Family Code                                                  Financial Code

Fish &  Game Code                                       Food and Agricultural Code

Government Code                                        Harbors and Navigation Code

Health & Safety Code                                  Insurance Code

Labor Code                                                   Military and Veterans Code

Penal Code                                                   Probate Code

Public Contract Code                                    Public Resources Code

Public Utilities Code                                       Revenue and Taxation Code

Streets and Highway Code                           Unemployment Insurance Code

Vehicle Code                                                  Water Code

Welfare and Institutions Code                     



4:38:15 PM    comment []

Case Specific Resources and Free Legal Consultations

Black=Free Legal Consultation 
Red=Government, Medical Website or Third Party Sources


11:41:34 AM    comment []

© Copyright 2005 Personal Injury Lawyers.
 
September 2005
Sun Mon Tue Wed Thu Fri Sat
        1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30  
Jun   Oct

Home

Click here to visit the Radio UserLand website.

Subscribe to "Personal Injury Lawyers' Radio Weblog" in Radio UserLand.

Click to see the XML version of this web page.

Click here to send an email to the editor of this weblog.